Delayed-type hypersensitivity in palmoplantar pustulosis: Effect of cyclosporin A treatment on skin testing with recall antigens

Acta Dermato-Venereologica

Volumn 76, Issue 4, 1996, Pages 310-313

  Remitz, Anita ^a   Lauerma, Antti I ^a   Erkko, Pekka ^a   Reitamo, Sakari ^a  

^a UNIVERSITY OF HELSINKI   (Finland)

Author keywords

Double blind study; Intradermal test; Mechanism of drug action

Indexed keywords

CYCLOSPORIN A; PLACEBO;

ADULT; ARTICLE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DELAYED HYPERSENSITIVITY; DOUBLE BLIND PROCEDURE; FEMALE; HUMAN; MAJOR CLINICAL STUDY; MALE; PRIORITY JOURNAL; PUSTULOSIS PALMOPLANTARIS;

EID: 0030018645     PISSN: 00015555     EISSN: None     Source Type: Journal    
DOI: 10.2340/0001555576310313     Document Type: Article

References (18)

1. Müller W, Herrmann B. Cyclosporin A for psoriasis. N Engl J Med 1979; 301: 555.
2. Ellis CN, Fradin MS, Messana JM, Brown MD, Siegel MT, Hartley AH, et al. Cyclosporine for plaque-type psoriasis. Results of a multidose, double-blind trial. N Engl J Med 1991; 324: 277-284.
3. Sowden JM, Berth-Jones J, Ross JS, Motley RJ, Marks R, Finlay AY, et al. Double-blind, controlled, crossover study of cyclosporin in adults with severe refractory atopic dermatitis. Lancet 1991; 338: 137-140.
4. Reitamo S, Erkko P, Remitz A, Lauerma AI, Montonen O, Harjula K. Cyclosporine in the treatment of palmoplantar pustulosis. A randomized, double-blind, placebo-controlled study. Arch Dermatol 1993; 129: 1273-1279.
5. Ho VC, Lui H, McLean DI. Cyclosporine in non-psoriatic dermatoses. J Am Acad Dermatol 1990; 23: 1248-1259.
6. Groisser DS, Griffiths CEM, Ellis CN, Voorhees JJ. A review and update of the clinical uses of cyclosporine in dermatology. Dermatol Clin 1991; 9: 805-817.
7. Granelli-Piperno A, Keane M, Steinman RM. Evidence that cyclosporine inhibits cell-mediated immunity primarily at the level of the T lymphocyte rather than the accessory cell. Transplantation 1988; 46 (Suppl 2): 53S-60S.
8. Kanitakis J, Thivolet J. Cyclosporine. An immunosuppressant affecting epithelial cell proliferation. Arch Dermatol 1990; 126: 369-375.
9. Nickoloff BJ, Fisher GJ, Mitra RS, Voorhees JJ. Additive and synergistic antiproliferative effects of cyclosporin A and gamma interferon on cultured human keratinocytes in vitro. Am J Pathol 1988; 131: 12-18.
10. Kniker WT, Anderson CT, Roumianteff M. The multi-test system: a standardized approach to evaluation of delayed hypersensitivity and cell-mediated immunity. Ann Allergy 1979; 43: 72-79.
11. Bland JM, Altman DG. Statistical methods for assessing agreement between two methods of clinical measurement. Lancet 1986; 1: 307-310.
12. Van der Heyden AAPAM, van Oers MHJ, Cornelissen P, Yong S-L, Wilmink JM, Schellekens PTA. The influence of cyclosporine A treatment on immune responsiveness in vitro and in vivo in kidney transplant recipients. Transplant Proc 1988; 20(Suppl 2): 190-195.
13. Krueger GG, Hill HR, Jederberg WW. Inflammatory and immune cell function in psoriasis - a subtle disorder. I. In vivo and in vitro survey. J Invest Dermatol 1978; 71: 189-194.
14. Obalek S, Haftek M, Glinski W. Immunological studies in psoriasis: the quantitative evaluation of cell-mediated immunity in patients with psoriasis by experimental sensitization to 2,4-dinitrochlorobenzene. Dermatologica 1977; 155: 13-25.
15. McFadden JP, Powles AV, Baker BS, Valdimarsson H, Fry L. Intradermal antigen tests in psoriasis. Acta Derm Venereol (Stockh) 1990; 70: 262-264.
16. Higgins EM, McLelland J, Friedmann PS, Matthews JNS, Shuster S. Oral cyclosporine inhibits the expression of contact hypersensitivity in man. J Dermatol Sci 1991; 2: 79-83.
17. Flori L, Perotti R, Mazzatenta C, Andreassi L. Cyclosporin A in the treatment of severe allergic contact dermatitis. J Eur Acad Dermatol Venereol 1993; 2: 200-206.
18. Munro CS, Higgins EM, Marks JM, Daly BM, Friedmann PS, Shuster S. Cyclosporin A in atopic dermatitis: therapeutic response is dissociated from effects on allergic reactions. Br J Dermatol 1991; 124: 43-48.